Press Releases

Biopharmaceuticals Major Challenge: The University of Évry and Genopole present in three of the eight laureate projects

ART-TG, CiTHERA, I-Stem and Yposkesi are contributing their expertise to three projects named on 3 February 2022 as laureates for the French Government's Major Challenges program.

02 March 2022

IGEM 2021: Yet another Gold Medal!

19 novembre 2021 – Pour la 5ème année consécutive, l’équipe d’Évry décroche une médaille d’or au célèbre concours international en biologie de synthèse iGEM, grâce à son projet « Evolution T7 » reposant sur l’évolution génétique dirigée et ouvrant un vaste champ d’applications.

19 November 2021

Algentech: High-Yield Molecular Farming Of Industrial Ingredients In Plant Chloroplasts

22 juin 2021 – Algentech, a Genopole-accredited French company, has achieved a world's first with its disruptive technology . The company's patented method enables the production of proteins and nucleic acids in plant chloroplasts.

22 June 2021

Genopole earns EU|BIC certification

5 décembre 2020 The European Commission's European Business Network (EBN) voted unanimously to certify Genopole as a European Union | Business and Innovation Center (EU|BIC), thus recognizing France's leading biocluster as a key contributor to R&D and Innovation in Genomics in France and Europe.

5 December 2020

Enalees announces clinical trial for a COVID-19 test

16 septembre 2020 – C4Diagnostics, Bertin Technologies and Enalees announced the launch of a prospective clinical trial for BEC-SARS-CoV-2 for humans, a rapid, point-of-care diagnostic for COVID-19.

16 September 2020

Ÿnsect obtains market approval for an insect-based fertilizer

17 juin 2020 – Ÿnsect has just gained approval for its natural insect fertilizer “ŸnFrass” issued by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety. Ÿnsect thus becomes the first company in the world to obtain certification and marketing approval for a natural insect-based fertilizer.

17 June 2020

Pharnext – A novel strategy to rapidly reposition drugs using existing COVID-19 clinical data

23 mars 2020 – Pharnext annonce l’identification de 97 médicaments fréquemment prescrits, au moyen de sa plateforme de Pleotherapy, comme candidats potentiels au repositionnement dans le traitement du COVID-19.

23 March 2020

A Friendly Takeover Bid Initiated by OncoDNA on IntegraGen

July 09, 2020 This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.

9 July 2020

IntegraGen renews its agreement with the Institut Pasteur

11 mars 2020 – IntegraGen announces the renewal of its partnership agreement with the Institut Pasteur until December 2021 related to high-throughput sequencing operations for microbiology activities carried out at the Institut Pasteur

11 March 2020

AB Science : masitinib’s potential mode of action in Alzheimer’s Disease

July 08, 2020 – AB Science SA announced the publication of preclinical study results with masitinib in Alzheimer’s disease entitled, ‘Effects of chronic masitinib treatment in APPPS1dE9 transgenic mice modeling Alzheimer’s disease’.

8 July 2020

Algentech Granted US Patent For A Key Genome Editing Technology

16 janvier 2020- Algentech annonce la délivrance d'un brevet clé dans le domaine de l'édition du génome par l'Office des brevets des États-Unis

16 January 2020